These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5811396)

  • 1. Fusaric acid, a hypotensive agent produced by fungi.
    Hidaka H; Nagatsu T; Takeya K; Takeuchi T; Suda H
    J Antibiot (Tokyo); 1969 May; 22(5):228-30. PubMed ID: 5811396
    [No Abstract]   [Full Text] [Related]  

  • 2. [Toxicobiological properties of fusaric acid].
    Bilai VI; Cherkes OI; Bogomolova LO; Frantsuzova SB
    Mikrobiol Zh; 1975; 37(3):325-8. PubMed ID: 1214653
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of dopamine beta-hydroxylase by 5-alkylpicolinic acid and their hypotensive effects.
    Suda H; Takeuchi T; Nagatsu T; Matsuzaki M; Matsumoto I; Umezawa H
    Chem Pharm Bull (Tokyo); 1969 Nov; 17(11):2377-80. PubMed ID: 5363295
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological action of FD-008, a new dopamine beta-hydroxylase inhibitor. I. Effects on blood pressure in rats and dogs.
    Ishii Y; Fujii Y; Mimura Ch; Umezawa H
    Arzneimittelforschung; 1975 Jan; 25(1):55-9. PubMed ID: 1173769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of fusaric acid, inhibitor of dopamine -hydroxylase, on reaction to alcohol in chronic alcoholics: clinical findings.
    Ogata M; Sanada H; Teraoka M
    Folia Psychiatr Neurol Jpn; 1972 Jan; 26(1):1-5. PubMed ID: 5068469
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical trial of a new hypotensive agent, "fusaric acid (5-butylpicolinic acid)": the preliminary report.
    Terasawa F; Kameyama M
    Jpn Circ J; 1971 Mar; 35(3):339-57. PubMed ID: 4932992
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fundamental studies on fusaric acid and calcium fusarate. Acute toxicity and antihypertensive effects (author's transl)].
    Matsuzaki M; Nakamura K; Akutsu S; Onodera K; Sekino M
    Jpn J Antibiot; 1976 May; 29(5):439-55. PubMed ID: 933335
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenal tyrosine hydroxylase and dopamine beta-hydroxylase in spontaneously hypertensive rats.
    Nagatsu I; Nagatsu T; Mizutani K; Umezawa H; Matsuzaki M; Takeuchi T
    Nature; 1971 Apr; 230(5293):381-2. PubMed ID: 4927727
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of dopamine beta-hydroxylase by fusaric acid (5-butylpicolinic acid) in vitro and in vivo.
    Nagatsu T; Hidaka H; Kuzuya H; Takeya K; Umezawa H
    Biochem Pharmacol; 1970 Jan; 19(1):35-44. PubMed ID: 5507649
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological studies of fusaric acid. II. (author's transl)].
    Matsuzaki M; Onodera K; Nakajima A; Kamei E; Koshino M
    Jpn J Antibiot; 1976 Apr; 29(4):419-29. PubMed ID: 819677
    [No Abstract]   [Full Text] [Related]  

  • 11. [Substituted picolinic acids as DBH inhibitors. Inhibition of dopamine beta-hydroxylase and antihypertensive action].
    Piesche L; Hilse H; Oehlke J; Schrötter E; Oehme P
    Pharmazie; 1983 May; 38(5):335-8. PubMed ID: 6611632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dopamine-beta-hydroxylase inhibitors on blood pressure and cardiac norepinephrine levels in rats subjected to immobilization stress.
    Ishii Y; Mimura C; Homma M
    J Pharmacol Exp Ther; 1976 Sep; 198(3):589-95. PubMed ID: 988175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusaric (5-butylpicolinic) acid, an inhibitor of dopamine beta-hydroxylase, affects serotonin and noradrenaline.
    Hidaka H
    Nature; 1971 May; 231(5297):54-5. PubMed ID: 4930475
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of fusaric acid and its derivative on the cardiovascular system].
    Furuta Y; Washizaki M
    Nihon Yakurigaku Zasshi; 1976 Mar; 72(2):139-44. PubMed ID: 987962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine -hydroxylase inhibitor produced by Gloeophyllum striatum and its identity with oosponol.
    Umezawa H; Iinuma H; Ito M; Matsuzaki M; Takeuchi T
    J Antibiot (Tokyo); 1972 Apr; 25(4):239-42. PubMed ID: 5051000
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation and characterization of two new fusaric acid analogs from Fusarium moniliforme NRRL 13,163.
    Burmeister HR; Grove MD; Peterson RE; Weisleder D; Plattner RD
    Appl Environ Microbiol; 1985 Aug; 50(2):311-4. PubMed ID: 4051483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCH 10595, an effective dopamine- -hydroxylase inhibitor and a hypotensive agent.
    Korduba CA; Veals J; Wohl A; Symchowicz S; Tabachnick II
    J Pharmacol Exp Ther; 1973 Mar; 184(3):671-7. PubMed ID: 4687230
    [No Abstract]   [Full Text] [Related]  

  • 18. Phenopicolinic acid, a new microbial product inhibiting dopamine beta-hydroxylase.
    Nakamura T; Yasuda H; Obayashi A; Tanabe O; Matsumura S
    J Antibiot (Tokyo); 1975 Jun; 28(6):477-8. PubMed ID: 1150540
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective suppression of rapid eye movement sleep (REM) by fusaric acid, an inhibitor of dopamine- -oxidase.
    Sato T; Tanaka R
    Experientia; 1973 Feb; 29(2):177-8. PubMed ID: 4348192
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of dopamine beta-hydroxylase in blood vessels by picolinic acid derivatives in vivo and their anthypertensive effects.
    Hidaka H; Shoka F; Hashizume Y; Takemoto N; Yamamoto M
    Jpn J Pharmacol; 1975 Oct; 25(5):515-24. PubMed ID: 1221134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.